110 related articles for article (PubMed ID: 5883214)
1. Analogs of tetrahydrofolic acid. XXVII. Hydrophobic bonding to dihydrofolic reductase by 2-amino-4,6-disubstituted-5-alkylpyrimidines and 1-alkyl-4,6-diamino-1,2-dihydro-s-triazines.
Baker BR; Beng-Thong Ho; Santi DV
J Pharm Sci; 1965 Oct; 54(10):1415-24. PubMed ID: 5883214
[No Abstract] [Full Text] [Related]
2. Irreversible enzyme inhibitors. LXXXVI. Hydrophobic bonding to dihydrofolic reductase. 8. Substituted-1-aryl-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazines.
Baker BR; Ho BT; Lourens GJ
J Pharm Sci; 1967 Jun; 56(6):737-42. PubMed ID: 5231391
[No Abstract] [Full Text] [Related]
3. Analogs of tetrahydrofolic acid XXV. 2,4-Diamino-6-phenethylpteridine, an inhibitor of dihydrofolic reductase.
Baker BR; Ho BT
J Pharm Sci; 1965 Sep; 54(9):1261-5. PubMed ID: 5881216
[No Abstract] [Full Text] [Related]
4. Analogs of tetrahydrofolic acid. 33. Hydrophobic bonding to dihydrofolic reductase V. Inhibition by some pyrimidines bridged to benzoic acid.
Baker BR; Ho BT; Coward JK; Santi DV
J Pharm Sci; 1966 Mar; 55(3):302-8. PubMed ID: 5960176
[No Abstract] [Full Text] [Related]
5. Analogs of tetrahydrofolic acid 34. Hydrophobic bonding to dihydrofolic reductase VI. Mode of phenyl binding of some 6-arylpyrimidines.
Baker BR; Shapiro HS
J Pharm Sci; 1966 Mar; 55(3):308-17. PubMed ID: 5960177
[No Abstract] [Full Text] [Related]
6. Analogs of tetrahydrofolic acid XXIV. Further observations on the mode of pyrimidyl binding to dihydrofolic reductase and thymidylate synthetase by the 2-amino-5-(3-anilinopropyl)-6-methyl-4-pyrimidinol type of inhibitor.
Baker BR; Santi DV
J Pharm Sci; 1965 Sep; 54(9):1252-7. PubMed ID: 5881214
[No Abstract] [Full Text] [Related]
7. Analogs of tetrahydrofolic acid XX. Effects of modification of the bridge between the pyrimidyl and phenyl moieties of 2-amino-5-(3-anilinopropyl)-6-methyl-4-pyrimidinol on inhibition of dihydrofolic reductase and thymidylate synthetase II.
Baker BR; Ho BT
J Pharm Sci; 1965 Aug; 54(8):1187-90. PubMed ID: 5882225
[No Abstract] [Full Text] [Related]
8. Irreversible enzyme inhibitors. LXXXVII. Hydrophobic bonding to dihydrofolic reductase. IX. Mode of binding of m-aryloxyalkyl groups on 4,6-diamino-1,2-dihdro-2,2-dimethyl-1-phenyl-s-triazine.
Baker BR; Lourens GJ
J Pharm Sci; 1967 Jul; 56(7):871-5. PubMed ID: 6068108
[No Abstract] [Full Text] [Related]
9. Analogs of tetrahydrofolic acid. 32. Hydrophobic bonding to dihydrofolic reductase IV. Inhibition by p-substituted benzoic and benzoyl-L-glutamic acids.
Baker BR; Schwan TJ; Novotny J; Ho BT
J Pharm Sci; 1966 Mar; 55(3):295-302. PubMed ID: 5960175
[No Abstract] [Full Text] [Related]
10. Irreversible enzyme inhibitors. CX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. IV.
Baker BR; Lourens GJ
J Med Chem; 1968 Jan; 11(1):34-7. PubMed ID: 5237172
[No Abstract] [Full Text] [Related]
11. Irreversible enzyme inhibitors. LXX. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. IV. Substituted 1-phenyl-1,2-dihydro-s-triazines.
Baker BR; Ho BT
J Pharm Sci; 1967 Jan; 56(1):28-32. PubMed ID: 6030489
[No Abstract] [Full Text] [Related]
12. Irreversible enzyme inhibitors. CIX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. 3.
Baker BR; Lourens GJ
J Med Chem; 1968 Jan; 11(1):26-33. PubMed ID: 5237171
[No Abstract] [Full Text] [Related]
13. Irreversible enzyme inhibitors. CXII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine substituted with a terminal sulfonyl fluoride. II.
Baker BR; Lourens GJ
J Med Chem; 1968 Jan; 11(1):38-41. PubMed ID: 5237173
[No Abstract] [Full Text] [Related]
14. 4,6-DIAMINO-1-ALKYL-1,2-DIHYDRO-S-TRIAZINES.
LOMBARDINO JG
J Med Chem; 1963 Mar; 6():213-4. PubMed ID: 14188803
[No Abstract] [Full Text] [Related]
15. Analogs of tetrahydrofolic acid XXII. Effects of modification of the bridge between the pyrimidyl and phenyl moieties of 2-amino-5-(3-anilinopropyl)-6-methyl-4-pyrimidinol thymidylate synthetase. 3.
Baker BR; Coward JK
J Pharm Sci; 1965 May; 54(5):714-9. PubMed ID: 5847011
[No Abstract] [Full Text] [Related]
16. Irreversible enzyme inhibitors. CLX. Some factors in cell wall transport of active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(phenylalkylphenyl)-s-triazines.
Baker BR; Janson EE; Vermeulen NM
J Med Chem; 1969 Sep; 12(5):898-902. PubMed ID: 5812208
[No Abstract] [Full Text] [Related]
17. Irreversible enzyme inhibitors. 133. Studies on differential irreversible inhibition of dihydrofolic reductase from three strains of L1210 leukemia, liver, spleen, and intestine of the mouse.
Baker BR; Lourens GJ; Meyer RB; Vermeulen NM
J Med Chem; 1969 Jan; 12(1):67-73. PubMed ID: 5763043
[No Abstract] [Full Text] [Related]
18. ANALOGS OF TETRAHYDROFOLIC ACID. XVII. ON THE MODE OF BINDING OF THE P-AMINOBENZOYL MOIETY OF N-(2-AMINO-4-HYDROXY-6-METHYL-5-PYRIMIDYLPROPYL)-P-AMINOBENZOYL-L-GLUTAMIC ACID TO DIHYDROFOLIC REDUCTASE.
BAKER BR; JORDAAN JH
J Med Chem; 1965 Jan; 8():35-41. PubMed ID: 14287264
[No Abstract] [Full Text] [Related]
19. Differential binding to the hydrophobic bonding region of T2 phage induced, Escherichia coli B, and pigeon liver dihydrofolic reductases.
Baker BR
J Med Chem; 1967 Sep; 10(5):912-7. PubMed ID: 4860445
[No Abstract] [Full Text] [Related]
20. Irreversible enzyme inhibitors. CLV. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 1-[4-(omega-aminoalkoxy)-3-chlorophenyl]-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazines bearing a terminal sulfonyl fluoride.
Baker BR; Janson EE
J Med Chem; 1969 Jul; 12(4):672-6. PubMed ID: 5793160
[No Abstract] [Full Text] [Related]
[Next] [New Search]
